🇺🇸 FDA
Patent

US 7045136

Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences

expired A61KA61K2039/5256A61K39/00

Quick answer

US patent 7045136 (Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/5256, A61K39/00, A61K39/12, A61K39/275